-
Study aim
-
Determining and comparing the effect of tecar therapy and phonophoresis on the improvement of carpal tunnel syndrome
-
Design
-
The randomized, double-blind clinical trial, with the parallel groups, on 50 patients
-
Settings and conduct
-
In this randomized double-blind clinical trial study, 50 eligible patients referred to Amin Hospital in Isfahan will be included in the study and randomly divided into 2 groups. Patients in the first group will undergo Tecar therapy, and patients in the second group will undergo phonophoresis. The intervention will be performed in such a way that the patient, the investigator, and the data analyst will not have any knowledge of the type of intervention and the conditions will be double-blind. Patients' symptoms and function will then be evaluated and compared between the two groups.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria include a mild to moderate carpal tunnel syndrome diagnosis by nerve and muscle strips and consent to participate in the study. Exclusion criteria include rheumatoid arthritis, diabetes, hypothyroidism, peripheral vascular disease, active cancer, cervical radiculopathy and polyneuropathy, pregnancy, a cardiac pacemaker, having a history of corticosteroid injection in the carpal tunnel area in the last quarter, and having a history of carpal tunnel syndrome surgery.
-
Intervention groups
-
Intervention group 1: Patients in this group will receive standard treatments. In addition, patients will receive Tecar therapy.
Intervention group 2: Patients in this group will receive standard treatments. In addition, patients will be treated with phonophoresis.
-
Main outcome variables
-
Symptoms and function of the syndrome; Cross-sectional area (CSA) of the median nerve; Pain